U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07843797) titled 'SAIL-MEVO: Endovascular Treatment Versus Best Medical Therapy for Distal Vessel Occlusions' on July 16.
Brief Summary: Patients with acute ischemic stroke caused by distal or medium vessel occlusions (MeVOs) may experience significant disability despite receiving the current standard medical treatment. Although endovascular treatment (EVT) is an established therapy for large vessel occlusions, its benefit in MeVO stroke remains uncertain.
The SAIL-MEVO trial is a prospective, multicenter, randomized controlled trial designed to evaluate whether EVT combined with best medical therapy improves functional outcomes compared with best ...